Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04708769 · ClinicalTrials.gov registry record · NA

Elements Vital to Treat Obesity Study

A NA study of Obesity, sponsored by Northwestern University.

Active
Registry status
NA
Development phase
524
Enrollment target
1
Study location

NCT04708769 is a NA study of Obesity that is active but no longer recruiting, run by Northwestern University. The registered enrollment target is 524 participants, below the 818-participant average among 1,053 other Obesity trials with a reported enrollment target (36% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04708769, a NA study of Obesity, is active but no longer recruiting, sponsored by Northwestern University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
524 participants
Enrollment target
1
Study location

Study Summary

The overall objective of this study is to evaluate the first rigorously optimized, remotely delivered treatment for obesity against the current gold standard treatment in a head-to-head randomized controlled trial. The investigators will be comparing the previously developed and optimized behavioral weight loss intervention (APP) to the Diabetes Prevention Program (DPP), to evaluate program weight-loss success and cost-effectiveness.

Conditions Studied

Interventions

  • BEHAVIORAL Smartphone App Participants (APP)
  • BEHAVIORAL Diabetes Prevention Program Participants (DPP)

Study Locations (1)

Illinois

  • Northwestern University - Chicago

Trial Details

FieldValue
Enrollment Target 524 participants
Start Date 2021-03-16
Est. Completion 2026-06-30
Phase NA

Sponsor

Northwestern University

1,209 total trials

What the Registry Record Tells You About NCT04708769

The ClinicalTrials.gov registry entry for NCT04708769 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 524 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 818-participant average among 1,053 other Obesity trials with a reported enrollment target (36% lower). The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Smartphone App Participants (APP) is the first listed.

NCT04708769 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT04708769 about?

NCT04708769 is a clinical study titled "Elements Vital to Treat Obesity Study". The overall objective of this study is to evaluate the first rigorously optimized, remotely delivered treatment for obesity against the current gold standard treatment in a head-to-head randomized controlled trial. The investigators will be comparing the previously developed and optimized behavioral...

What is the current status of trial NCT04708769?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 524 participants. The study started on 2021-03-16. Estimated completion is 2026-06-30.

What conditions does trial NCT04708769 study?

This clinical trial studies the following conditions: Obesity.

What interventions are being tested in trial NCT04708769?

The interventions under investigation include: Smartphone App Participants (APP) (BEHAVIORAL), Diabetes Prevention Program Participants (DPP) (BEHAVIORAL).

Who is sponsoring clinical trial NCT04708769?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04708769 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.